Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Agios Pharmaceuticals Inc
Woman and Man Max 99 years
Agios Pharmaceuticals Inc
Update Il y a 4 ans
A Phase 2, Open Label, Randomized, Dose Ranging, Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of AG-348 in Adult Patients with Pyruvate Kinase Deficiency
• Evaluate the safety and tolerability of up to 24 weeks of AG 348 administration in patients with PK deficiency.
Country
None
organs
None
Specialty
None
unknown
More information